Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 1756 AL 1770

Neuroprotective Action of Selected Natural Drugs Against Neurological Diseases and Mental Disorders: Potential Use Against Radiation Damage

Akhlada, Siddiqui N, Anurag, Saifi A, Kesharwani A, Parihar VK, Sharma A.

Neurochem Res. 2024 Sep;49(9):2336-2351. doi: 10.1007/s11064-024-04184-y. Epub 2024 Jun 12.

Neuromodulatory effects of leukotriene receptor antagonists: A comprehensive review

Sood R, Anoopkumar-Dukie S, Rudrawar S, Hall S.

Eur J Pharmacol. 2024 Sep 5;978:176755. doi: 10.1016/j.ejphar.2024.176755. Epub 2024 Jun 21.

Challenges and Future Perspectives in Modeling Neurodegenerative Diseases Using Organ-on-a-Chip Technology

Pramotton FM, Spitz S, Kamm RD.

Adv Sci (Weinh). 2024 Aug;11(32):e2403892. doi: 10.1002/advs.202403892. Epub 2024 Jun 23.

Introducing the Role of Genotoxicity in Neurodegenerative Diseases and Neuropsychiatric Disorders

Kisby GE, Wilson DM 3rd, Spencer PS.

Int J Mol Sci. 2024 Jun 29;25(13):7221. doi: 10.3390/ijms25137221.

Phenotypic Expansion of Autosomal Dominant LZTR1-Related Disorders with Special Emphasis on Adult-Onset Features

Uliana V, Ambrosini E, Taiani A, Cesarini S, Cannizzaro IR, Negrotti A, Serra W, Quintavalle G, Micale L, Fusco C, Castori M, Martorana D, Bortesi B, Belli L, Percesepe A, Pisani F, Barili V.

Genes (Basel). 2024 Jul 13;15(7):916. doi: 10.3390/genes15070916.

Adenylyl cyclase 2 expression and function in neurological diseases

Gray M, Nash KR, Yao Y.

CNS Neurosci Ther. 2024 Jul;30(7):e14880. doi: 10.1111/cns.14880.

Oxidative Cysteine Post Translational Modifications Drive the Redox Code Underlying Neurodegeneration and Amyotrophic Lateral Sclerosis

Percio A, Cicchinelli M, Masci D, Summo M, Urbani A, Greco V.

Antioxidants (Basel). 2024 Jul 23;13(8):883. doi: 10.3390/antiox13080883.

Interpretation of Neurodegenerative GWAS Risk Alleles in Microglia and their Interplay with Other Cell Types

Holtman IR, Glass CK, Nott A.

Adv Neurobiol. 2024;37:531-544. doi: 10.1007/978-3-031-55529-9_29.

The role of thyroid-stimulating hormone in regulating lipid metabolism: Implications for body-brain communication

Wang X, Wu Z, Liu Y, Wu C, Jiang J, Hashimoto K, Zhou X.

Neurobiol Dis. 2024 Oct 15;201:106658. doi: 10.1016/j.nbd.2024.106658. Epub 2024 Sep 3.

Optimizing cryopreservation strategies for scalable cell therapies: A comprehensive review with insights from iPSC-derived therapies

Dobruskin M, Toner G, Kander R.

Biotechnol Prog. 2024 Nov-Dec;40(6):e3504. doi: 10.1002/btpr.3504. Epub 2024 Sep 13.

Progress of Astrocyte-Neuron Crosstalk in Central Nervous System Diseases

Zhang Y, Wang Z, Xu F, Liu Z, Zhao Y, Yang LZ, Fang W.

Neurochem Res. 2024 Dec;49(12):3187-3207. doi: 10.1007/s11064-024-04241-6. Epub 2024 Sep 18.

Review of Intranasal Active Pharmaceutical Ingredient Delivery Systems

Safarov R, Fedotova O, Uvarova A, Gordienko M, Menshutina N.

Pharmaceuticals (Basel). 2024 Sep 7;17(9):1180. doi: 10.3390/ph17091180.

Utilizing Multifaceted Approaches to Target Drug Delivery in the Brain: From Nanoparticles to Biological Therapies

Anwarkhan S, Koilpillai J, Narayanasamy D.

Cureus. 2024 Sep 1;16(9):e68419. doi: 10.7759/cureus.68419. eCollection 2024 Sep.

Real-time TMS-EEG for brain state-controlled research and precision treatment: a narrative review and guide

Wischnewski M, Shirinpour S, Alekseichuk I, Lapid MI, Nahas Z, Lim KO, Croarkin PE, Opitz A.

J Neural Eng. 2024 Nov 1;21(6):061001. doi: 10.1088/1741-2552/ad8a8e.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias